370. The comparison of adverse events in combination with double beta-lactam antimicrobials: Ampicillin plus Ceftriaxone and Ampicillin/Cloxacillin with bloodstream infections

BACKGROUND: Double beta-lactams are used to treat infective endocarditis, but the incidence rate of adverse events is unclear. We aimed to compare the incidence rates of adverse events of ampicillin(ABPC) versus ABPC plus ceftriaxone(CTRX) and ABPC/MPIPC(cloxacillin). METHODS: We retrospectively inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishikawa, Kazuhiro, Kobayashi, Daiki, Mori, Nobuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676930/
http://dx.doi.org/10.1093/ofid/ofad500.440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676930/
http://dx.doi.org/10.1093/ofid/ofad500.440

Ejemplares similares